To explore whether the TGFα/EGFR axis could play a role in the pathophysiology of kidney cancer, we used genetic and pharmacologic approaches to explore the effect of targeting the EGFR on the proliferation of kidney cancer cells. This evidence concerns the gene TGFA and kidney cancer.